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Abstract: Damage to our genomes triggers cellular senescence characterised by stable cell cycle arrest
and a pro-inflammatory secretome that prevents the unrestricted growth of cells with pathological
potential. In this way, senescence can be considered a powerful innate defence against cancer and viral
infection. However, damage accumulated during ageing increases the number of senescent cells and
this contributes to the chronic inflammation and deregulation of the immune function, which increases
susceptibility to infectious disease in ageing organisms. Bacterial and viral pathogens are masters of
exploiting weak points to establish infection and cause devastating diseases. This review considers
the emerging importance of senescence in the host–pathogen interaction: we discuss the pathogen
exploitation of ageing cells and senescence as a novel hijack target of bacterial pathogens that deploys
senescence-inducing toxins to promote infection. The persistent induction of senescence by pathogens,
mediated directly through virulence determinants or indirectly through inflammation and chronic
infection, also contributes to age-related pathologies such as cancer. This review highlights the
dichotomous role of senescence in infection: an innate defence that is exploited by pathogens to
cause disease.
Keywords: viral and bacterial infections; DNA damage; senescence; microbial replication; bacterial
genotoxins; cancer; tissue microenvironment
1. Introduction
Cellular senescence is a process by which cells undergo stable cell cycle arrest and phenotypic
changes, including modifications of chromatin and a pro-inflammatory secretome that prevents
the unrestricted growth of damaged cells [1,2]. Consequently, senescence represents an important
innate defence against pathologies that hijack cellular proliferation to cause disease. Different types of
senescence have been identified such as replicative senescence (RS), oncogene-induced senescence (OIS),
genotoxicity-induced senescence (GIS), developmental senescence (occurring during embryogenesis)
and tissue repair senescence [2–4].
OIS represents a major tumour suppressor mechanism while senescence can also restrict
viral replication. Senescent cells release a pro-inflammatory secretome that underlies the
senescence-associated secretory phenotype (SASP), which impacts diverse biological processes in the
tissue microenvironment through paracrine signalling [5]. SASP can induce paracrine senescence in
bystander cells, as well as the inflammation and infiltration of innate immune cells that further restrict
the threat posed by cells with pathological potential [5–7].
The rapid ‘acute’ forms of senescence, in response to overwhelming DNA damage, represent a
safeguard against the ill health of an organism [8]. Other beneficial roles of acute senescence include
development, tissue homeostasis and wound healing where myofibroblasts undergo acute senescence
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to limit scarring [8,9]. However, there are two sides to cellular senescence, which can also cause disease.
This is exemplified by acute OIS [7,10] and chronic senescence caused by cells experiencing mild and
persistent genotoxic stress [8,11]. Chronic senescence is detrimental to an organism and contributes
to age-related pathologies such as cancer, cardiovascular disease, diabetes, and neurodegenerative
disorders [8,12–14]. Ageing cells accumulate macromolecular damage, which leads to the stochastic
build-up of senescent cells and chronic inflammation via SASP resulting in genomic instability and
pathology [12,14,15]. Thus, senescence can be viewed as a good servant but a bad master that can tip
the balance in favour of disease.
Pathogens are masters of subverting biological processes for their own gain during infection, yet it
was not until relatively recently that senescence has emerged as a possible hijack target [16–23].
Bacterial and viral pathogens possess armouries of virulence factors that have the potential
to induce senescence responses either directly (e.g., dedicated bacterial toxins) or indirectly
(e.g., fundamental pathogen-associated molecular patterns such as viral capsids, bacterial flagella
and lipopolysaccharide) [23]. In this review, we discuss senescence as an emerging hijack target of
pathogens and consider how collateral damage resulting from infection might contribute to age-related
diseases. We discuss senescence in the context of combatting pathogens and mobilising innate immune
responses, and incorporate the lessons learnt from viral infections to present a current view on the
senescence host–pathogen interaction.
2. Hallmarks of Cellular Senescence
The cellular and molecular features of senescent cells are complex and can vary depending on
several parameters such as the cell type, stressor, intensity and length of the stimulus.
Four key parameters have been identified as associated with the senescent phenotype: irreversible
cell cycle arrest, the secretion of soluble mediators and extracellular vesicles (SASP or senescence
messaging secretome, SME), the damage of macromolecules (DNA, proteins and lipids) and altered
metabolism ([2]). Considering the multiple triggering factors, the characterisation of senescent cells is
not unequivocal and requires a multi-marker approach, as summarised in ([2]).
In this section, we will focus on the aspects of senescence relevant for host–pathogen interaction:
cell cycle arrest, DNA damage, resistance to apoptosis and SASP (Figure 1).
The key feature of senescent cells is their permanent exit from the cell cycle progression,
the enhanced activity of the lysosomal senescence-associatedβ-galactosidase (SA-β-gal), the acquisition
of a flatten morphology, granular phenotype, and enlarged nucleus [2,24].
The permanent cell cycle arrest in senescent cells is dependent on the activation of the cyclin
kinase inhibitors p21WAF/Cip1 (CDKN1A), p16INKA (CDKN2A) and p15INK4b (CDKN2B).
The p21 is a transcriptional target of p53 and a potent inhibitor of several cyclin/cyclin kinase
complexes, including cyclins E/A-CDK2, cyclin A-CDK1, and cyclin Ds-CDK4,6, therefore p21 promotes
cell cycle arrest in different phases of the cell cycle, depending of the cyclin/CDK complex targeted.
p16 and p15 inhibit the cyclinDs-CDK4,6 resulting in the accumulation of the hypophosphorylated form
of the tumour suppressor retinoblastoma (RB) protein, arresting the cell at the G1/S transition [25–27].
The presence of persistent DNA damage is a strong trigger of senescence. RS is caused by
telomere shortening during cellular replication, which results in the telomere uncapping and activation
of the DNA damage response (DDR) [28]. Conversely, OIS is the consequence of the sustained
replication promoted by oncogene overexpression, which leads to the collapse of the replication forks,
the induction of DNA damage and DDR activation, a phenomenon considered a powerful barrier for
cancer development [29]. In addition, chronic exposure to endogenous or exogeneous DNA damaging
agents, such as ionizing and ultraviolet radiations, oxidative stress, chemotherapeutics, and bacterial
toxins, triggers senescence [30]. The chronic activation of DDR can be visualised at the DNA damaged
site by the detection of the phosphorylated form of the ataxia telangectasia mutated (ATM) kinase
(Ser1981), histone H2A phosphorylation (γH2AX, Ser 139), p53 (Ser15), CHK2 (Thr68), the recruitment
of adaptor and repair proteins such as MDC1, NBS1, MRE11, 53BP1, CHK2, and at a later stage of the
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promyelocytic leukaemia protein (PML) nuclear bodies, in structures known as DNA fragments with
chromatin alteration reinforcing senescence (DNA-SCARS) [31].
Figure 1. Senescence-triggering factors and the features of senescent cells. The figures summarised
the four key features of senescence relevant for the host–pathogen interaction (cell cycle arrest,
DNA damage response, SASP and resistance to apoptosis), and the key molecules involved in
each of these processes. Senescence can be induced by several stimuli, such as telomeres erosion
(replicative senescence), the over-activation of oncogenes, which will induce replication stress and
consequent chronic DNA damage (oncogene-induced senescence), chronic DNA damaged caused
by exogenous or endogenous genotoxic agents (e.g., chemotherapy, irradiation, oxidative stress,
genotoxic-induced senescence). Physiological types of senescence also occur during embryonic
development (developmental senescence) or tissue repair.
Another type of DNA damage detected in senescent cells is the presence of cytoplasmic chromatin
fragments (CCFs). Due to the unusual location, CCFs are perceived by the cell as a threat, triggering
the activation of the cGAS-STING-mediated innate response, leading to the production and secretion
of type I interferon (IFN-I) [32–35], thus contributing to the secretory phenotype of senescent cells
(see below).
The permanent quiescent state of senescent cells contrasts with their capacity to secrete a plethora
of mediators (namely SASP) contributing to the remodelling of the surrounding microenvironment in
a paracrine and juxtacrine manner [7,36–39].
SASP is regulated by the activation of transcription factors and signalling pathways, many
of these associated with the induction and secretion of pro-inflammatory mediators (e.g., IL-1α,
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IL-6, IL-8, growth factors, and extracellular matrix metalloproteases), including NFκB and C/EBPβ,
the inflammasome, the p38 MAPK and mTOR pathways [7,40,41]. However, recent evidence indicates
that the composition of SASP can differ, depending on the genetic background or the time after
the senescence is triggered. Indeed, the JAK2-activated STAT3 transcription factor promotes an
immune suppressive SASP in phosphatase and angiotensin homologue (PTEN)-deficient prostate
cancer cells, characterised by secretion of IL-10 and IL-13 [42]. On the other hand, oncogene- or DNA
damage-induced senescence induces the transient activation of the NOTCH1 signalling pathway in
human diploid fibroblasts, leading to the suppression of pro-inflammatory cytokine production, via the
inhibition of C/EBPβ [39]. These data indicate that SASP composition and the consequent modulation
of the microenvironment is complex, possibly due to different SASPs, depending on the temporal and
spatial induction of senescence. This feature may be exploited by microorganisms to manipulate the
host microenvironment in order to establish a successful infection.
Several lines of evidence demonstrate that senescent cells are more resistant to apoptosis in
response to genotoxic, oxidative and endoplasmic reticulum (ER) stress [24]. This resistance is
dependent on the activation of several pathways, and considering the heterogenicity of the triggering
signals, the survival mechanisms may be different in the different types of senescence. DNA damage
leads to the activation of the transcription factor NFκB, which is a key contributor to the SASP but
also upregulates the expression of pro-survival genes such as BCL-2 [43]. DNA damage as well as
growth factors (e.g., IGF-1) secreted by the senescent cells activate the PI3K–AKT axis, which results
in (i) the phosphorylation of pro-apoptotic protein BAD and its dissociation from the BAD/Bcl-XL
complex [44]; (ii) the phosphorylation and inactivation of the transcription factor FOXO3, and the
consequent downregulation of the pro-apoptotic BH3-only members of the BCL2 family (BIM BIK,
NOXA, PUMA) [45].
The secretory phenotype of senescent cells is associated with intense ER stress, due to the
accumulation of misfolded proteins triggering a process known as unfolded protein response (UPR)
that results in the remodelling and expansion of the ER membrane to cope with the high protein
secretion rate [24,46].
3. Infection and Senescence
Several aspects of senescence can be highlighted in infections: (a) immunosenescence due to
chronic infections; (b) regulation of microbial replication and invasion; (c) microorganism-induced
interference of senescence; (d) senescence and modulation of the tissue microenvironment (Figure 2).
In the next section, we will discuss these issues in the context of viral and bacterial infections.

 
ぼ
Figure 2. Crosstalk between cellular senescence and infections. Several aspects of senescence can be
highlighted in infections: (a) immunosenescence due to chronic infections, which can impair the host
immune responses and contribute to persistent infections; (b) the regulation of microbial replication
and invasion where senescent cells can either enhance microbial replication or act as innate immune
defence mechanisms limiting the rate of infection; (c) the microorganism-induced senescence, due to
the direct induction of chronic DNA damage either indirectly via chronic inflammation and consequent
oxidative stress, or directly by the production of genotoxins; (d) the senescence and modulation of the
tissue microenvironment, which can contribute to the establishment of a favourable niche to ensure a
successful infection.
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3.1. Immunosenescence
Aging is associated with a progressive loss of the immune system efficacy, which is detected both
within the innate immune compartment, and most prominently, in the effector cells of the adaptive
immune response: B and T lymphocytes [47,48].
Professional phagocytic cells, such as neutrophils and macrophages, show decreased phagocytic
capacity and oxidative burst. Parallel to the decline of these key antimicrobial effector functions,
peripheral bloodmononuclear cells from older individuals secrete higher amounts of pro-inflammatory
cytokines, including IL-1, IL-12 and TNF-α compared to the levels observed in the cells isolated form
younger donors [49,50], a condition that has been epitomised by the term ‘inflammageing’ [51,52].
Hallmarks of immunosenescence in the T and B cell compartment are: (i) the reduced ability to
respond to new antigenic stimuli; (ii) the accumulation of memory T cells (a process known as memory
inflation); (iii) the reduced diversity of the T and B cell receptors; (iv) the impaired ability of B cells
to produce high affinity antibodies; (v) the reduced serum levels of antibodies produced by naïve B
lymphocytes (IgD and IgM) [47,48].
Immunosenescence has been associated with several chronic viral infection, including human
cytomegalovirus (HCMV), human hepatitis C virus (HCV), human immunodeficiency virus (HIV) and
human acute T cell leukaemia virus type I (HTLV-1).
Immunosenescence and Chronic Viral Infections
HCMV is an enveloped double stranded DNA beta herpes virus that establishes a latent infection,
with periodic reactivation controlled by the host cytotoxic T lymphocytes (CTL) response in healthy
individuals [53]. Continued antigen exposure as seen in the HCMV infection (hyperantigenemia)
results in telomere erosion and replicative senescence, a processwhich occurs faster andmore frequently
in CD8+ cytotoxic T lymphocytes (CTL) compared to CD4+ T helper cells [54–56].
HCMV-specific CD8+ and CD4+ T lymphocytes exhibit features of immunosenescence
characterised by CD57 expression and reduced levels of CD27 and CD28. However, there is not
a general consensus whether this phenotype is associated with reduced telomere length [57–59].
HCMV-specific T lymphocytes can secrete higher levels of pro-inflammatory cytokines (IFN-γ and
TNF-α) upon stimulation [56], possibly contributing to the process of inflammageing, but exhibit poor
proliferative responses, possibly due to the eroded feature of their telomeres.
It is noteworthy that other markers of senescence, such as the activation of the DDR,
the upregulation of p21 or p16 have not been assessed in these studies, and the definition of
immunosenescent cells is based exclusively on surface marker expression. To understand their
physiological or pathological effects, it would be important to further characterise other features of
senescent cells in these T cell populations, including secretory phenotype.
HCV is an enveloped positive single-stranded RNA virus that infects the liver, inducing acute
hepatitis. However, 70–80% of infected individuals develop a chronic infection, which can result in
liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC) [60]. Memory T lymphocytes isolated
from the peripheral blood of HCV-positive patients present shorter telomeres compared to healthy
subjects [61]. In addition, CD8+ T cells show a sign of DNA damage as assessed by the detection
of γH2AX, and this subpopulation does not phosphorylate STAT1 and STAT5 in response to IL-6
or IL-2 stimulation, respectively, compared to unfractionated CD8+ T lymphocytes [62]. These data
suggest that chronic HCV infection promotes T cell immunosenescence, and as discussed above,
a more in-depth analysis of the senescence markers will contribute to a better characterisation of their
contribution to the disease progression.
The enveloped positive single-stranded RNA retrovirus HIV targets mainly CD4+ T lymphocytes
and results, if not treated, in a progressive loss of this cell population. The loss of the CD4+ T population
results in severe immunodeficiency characterised by susceptibility to infections and a certain type of
infection-associated cancer (Kaposi sarcoma and B cell lymphoma), a syndrome known as acquired
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immune deficiency syndrome (AIDS). The introduction of the anti-retroviral therapy (ART) resulted in
the suppression of viral replication, and strong reduction of risk to develop AIDS [63].
Recent studies demonstrate thatHIVpatients present T cell abnormalities similar to those identified
in elderly individuals, including the expansion of CD28 negative T cells, lower naive/memory ratios,
and reduced responsiveness to vaccine [64]. The expression of p16 is elevated in non-ART-treated
patients compared to uninfected subjects, and does not correlate with chronological age, suggesting
that active HIV infection is associated with immunosenescence. ART treatment reduces the levels of
p16 expression to those observed in healthy controls in the CD4+ compartment, but not in CD8+ T
lymphocytes [65,66].
Interestingly, HIV-specific CD8+ T cells have significantly shortened telomeres in patients with
progressive disease (progressors) compared to those observed in the limited group of HIV-positive
individuals who do not show an increase viremia (controllers). Blockage of the immunological
checkpoint with anti-PD-L1 specific antibody, promotes the upregulation of the telomerase and
consequent telomeres elongation, suggesting that the checkpoint inhibitor therapy may enhance
immune control against HIV-1 [67].
Similarly to HIV, the enveloped positive single-stranded RNA virus HTLV-1 infects CD4+ T
lymphocytes, and it is the causative agents of two diseases: acute T-cell leukaemia/lymphoma (ATLL)
and a demyelinating disease known as HTLV-1-associated myelopathy/tropical spastic paraparesis
(HAM/TSP) [68]. HTLV-1-infected cells isolated form the peripheral blood ofATLLpatients, andHTLV-1
transformed cell lines, show signs of telomere attrition. In the latter case, telomere shortening is
associated with the presence of telomere dysfunction-induced foci (TIF) and ATM phosphorylation:
both are characteristic signs of RS [69,70].
3.2. Effect of Senescence in Microbial Replication and Invasion
The number of persons over 60 years of age is expected to double from 11% of the world’s
population to 22% by 2050 [71]. An extended lifespan is also coupled with an increased susceptibility
to infection which can be associated with the declined efficacy of the immune system, as discussed in
the previous section. However, recent studies indicate that pathogenic bacteria exploit senescent cells
to establish infections in ageing organisms, thus the increased susceptibility of the elderly to infection
may be multifaceted.
3.2.1. Bacterial Infections
In rats, the aged animals are more susceptible to infection by Salmonella enterica serovar
Typhimurium [72], which invades the cells of the intestinal mucosa and is a leading cause of human
gastroenteritis [73]. The increased susceptibilitymay be due to senescence-induced increased caveolin-1
expression observed in ageing humans, rats and mice, which promotes enhanced Salmonella uptake in
non-phagocytic senescent fibroblasts in vitro [74].
RS and caveolin-1 have also been demonstrated to enhance the invasion of Fusobacterium nucleatum
in primary human gingival fibroblasts (GFs) [75]. Interestingly, in these settings F. nucleatum infection
promotes a reduction in IL-6 and IL-8 secretion in senescent cells compared to infected low passage
GFs, adding additional evidence to the fact that SASP can be differentially regulated under certain
conditions, such as infections.
Lower respiratory tract infection by Streptococcus pneumoniae is a leading cause of infection-related
fatalities in the elderly [76]. Age-associated inflammation in the lung is linkedwith increased senescence
markers (e.g., p16 expression) and SASP (e.g., IL-1α/β, IL-6, TNF-α and CXCL1), which is coincident
with an increased expression of S. pneumoniae cell-surface receptors keratin 10 (K10), laminin receptor
(LR) and platelet-activating factor receptor (PAFr) [77]. Senescent cells with increased K10 and LR
are more permissive for infection in vitro. In accordance with the in vitro data, the induction of
genotoxin stress in mice via the administration of bleomycin or H2O2 enhances the levels of p16, LR,
and pro-inflammatory cytokines in the lungs, aswell as the susceptibility to pneumococcal infection [77].
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The upregulation of senescence markers in old mice (p21) and the downregulation of S. pneumoniae
receptors (LR, K10 and PAFr) could be reversed by enteric administration of rapamycin, a known
inhibitor of the mTOR pathway, resulting in decreased tissue damage in the lungs and the increased
survival of mice upon infection [78].
3.2.2. Viral Infections
The elderly population is very susceptible to infection by the negative single-stranded RNA
influenza virus (IV) infection and the reactivation of the double stranded DNA varicella zoster virus
(VZV) [79,80]. Besides the reduced efficacy of the immune response, the increased susceptibility of
viral infection could be fuelled by an enhanced viral replication in senescent cells.
Recent evidence showed that primary human bronchial epithelial cells or humandermal fibroblasts
undergoing RS present increased susceptibility to both IV and VZV as assessed by increased viral
gene expression and virus titres compared to non-senescent cells [81]. The higher susceptibility of
senescent cells to viral infection could possibly be exploited to eliminate chemotherapy-induced
senescent cancer cells, which in vitro have been shown to undergo accelerated lysis upon infection
with the measle vaccine virus (MeV, a virus-dependent senolysis), thus suppressing the potential
pro-tumorigenic effects of the chronic SASP in the tumour microenvironment [82]. It is noteworthy
that infection with the MeV was performed on a panel of cancer cell lines 72 h after treatment with
chemotherapeutic drugs, such as doxorubicin, taxol and gemcitabine, and although senescence was
confirmed by SA-β-gal staining, it would be interesting to assess the virolytic effects after a longer
period of time.
The enhanced susceptibility of senescent cells to viral infections may be a direct consequence of
their ability to resist apoptosis and tolerate a high ER protein load, and/or it could be dependent on
an increased expression of the virus-specific receptors on the host cell surface. Interestingly, ACE-2,
the receptor for the SARS-CoV-2 virus [83], and the angiotensin system promote senescence in coronary
artery endothelial cells [84]. Whether this effect is associated with an enhanced viral entry and
replication in senescent cells has not been experimentally assessed, but it is an important aspect to be
addressed and may explain the high morbidity and mortality in elderly individuals.
Cellular senescence can also represent an innate defence mechanism to limit microbial replication.
This has been demonstrated for the negative-sense single-stranded RNA vesicular stomatitis virus
(VSV), which presents a significantly reduced ability to replicate in senescent mouse embryonic
fibroblasts (MEFs) or in tumour cell lines, such as A549 or MCF7. The biological relevance of this
finding has been validated in an in vivo model, where the induction of genotoxicity and consequent
senescence by the administration of bleomycin reduces viral recovery from the lungs of VSV-infected
mice 6 days post-infection [85]. Similarly, the infection of human primary dermal fibroblasts with
the double stranded DNAmerkel cell polyoma virus (MCPyV) activates the ATM-dependent DDR
response and KAP1-dependent senescence, resulting in a significant reduction of the viral replication
rate [86].
3.3. Microorganism-Induced Interference of Senescence
3.3.1. Induction of Senescence
Given the evidence that pathogenic bacteria exploit senescence to establish infections in ageing
organisms, it seems possible that bacteria have evolved virulence strategies to induce premature
senescence in target cells. Strategies may include inducing senescence indirectly via persistent
inflammatory responses [23]. For example, pathogen-associated molecular pattern (PAMP) molecules,
such as bacterial lipopolysaccharide, have been shown to induce stem cell senescence by the
persistent activation of the pattern recognition receptor Toll-like receptor 4 through the NFκB-p53-p21
signalling axis [87]. While it remains unclear whether bacteria exploit PAMPs as an indirect means to
hijack inflammation-mediated senescence, dedicated microbial genotoxins are becoming increasingly
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implicated in direct induction of senescence. Bacterial genotoxins are effectors that cause DNAbreaks in
mammalian cells [23,88,89]. Intoxication results in DDRs that orchestrate repair and cell fate decisions
including survival. However, if the DNA damage is too extensive, the damaged cells die by apoptosis
or enter senescence.
Colibactin produced by the B2 lineages of the enteric pathogen Escherichia coli causes DNA
replication stress during mammalian cell infection by inducing DNA interstrand cross-links,
which recruit the DNA cross-link repair Fanconi anemia protein D2 (FANCD2) and activates
the ATM-and-Rad3 related (ATR) kinase [90,91]. Infected cells often undergo cell death, but a
significant proportion display hallmarks of cellular senescence including enhanced SA-β-gal activity,
the expansion of PML bodies and senescence-associated heterochromatic foci (SAHF) [22]. The idea
that colibactin induces senescence was reinforced by evidence of SASP characterised by the secretion of
proinflammatory molecules (i.e., IL-6, IL-8, MCP1, MMP3) and transmissible senescence in bystander
cells that promoted cancer cell proliferation [22].
Foremost amongst bacterial genotoxins is the family of cytolethal distending toxins (CDTs)
encoded by diverse Gram-negative pathogenic bacteria. CDTs comprise a genotoxic CdtB subunit
with functional and structural homology to mammalian DNase-I, which is non-covalently linked
to the accessory CdtA and CdtC subunits that mediate CDT internalisation [92–94]. CDT nuclease
activity is thought to induce double-strand breaks (DSBs) and single-strand breaks (SSBs) in DNA that
trigger DDR, including ATM/ATR activation, cell cycle arrest and cellular distension [95–99]. Persistent
γH2AX/53BP1 DDR induced by Haemophilus ducreyi CDT was shown to induce the hallmarks of
premature cellular senescence in normal and cancer cell types [17]. The hallmarks included enhanced
SA-β-gal activity, the expansion of PML nuclear bodies and the expression of cytokines IL-6, IL-8,
and IL-24. The authors likened the CDT-induced senescence to an anti-cancer response that highlights
the potentially oncogenic effects of bacterial genotoxins. Consistent with this, the heterologous
expression of CdtB triggered a senescence-like response in tumour xenografts in mice [100].
While the direct induction of senescence by genotoxins further implicates bacteria in oncogenesis,
it is less clear whether senescence is subverted by pathogens to promote infection. One example recently
implicated in senescence includes the typhoid toxin [19], which is a unique chrimeric toxin encoded by
the serovars of the intracellular pathogen Salmonella that cause enteric fever (e.g., typhoidal serovars
S. Typhi, S. Paratyphi) and inflammatory gastroenteritis (e.g., non-typhoidal serovars S. Javiana,
S. Montevideo) in humans [101–103]. The typhoid toxin has been reported to play important roles
during the Salmonella infection of mice and humans including pathogen dissemination and host
colonisation, the suppression of inflammatory responses, bacteraemia, typhoid fever and chronic
Salmonella carriage [103–106]. The typhoid toxin mediates its toxigenic activities through CdtB,
which is exocytosed from infected mammalian cells in a chimeric complex with the pertussis toxin
subunits PltA and Plt, the latter facilitate toxin endocytosis into bystander cells where CdtB causes
DNA damage [102,103,107]. Recent work on the typhoid toxin revealed that senescence is hijacked
by S. Typhi and S. Javiana to enhance the intracellular Salmonella infection of macrophage and
fibroblast-like cells [19]. A senescent-like phenotype was triggered by two mutually exclusive DDRs
in distinct cell populations: ATM-dependent γH2AX foci in G1 or ATR-dependent γH2AX localised
at the nuclear periphery in G2/M, referred to as RING (response induced by a bacterial genotoxin).
The RING phenotypewas a result of excessive single-strandDNA breaks that sequestered the replisome
component replication protein A (RPA) and caused DNA replication stress. Consistent with this,
RPA exhaustion by small molecule inhibitors is known to cause replication catastrophe leading to
cellular senescence [108]. The toxin-induced DDRs led to SASP-containing unidentified factors,
which caused transmissible senescence in bystander cells that were more susceptible to Salmonella
infection [19]. This suggests that pathogenic bacteria hijack senescence to modulate the infection niche
as part of their virulent strategy, as discussed below.
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3.3.2. Inhibition of Senescence
While certain bacteria may actively promote senescence, other microorganisms have been shown
to negatively interfere with this process either to promote the proliferation of the host cells to ensure
their replication or to expand the pool of infected cells. Interestingly, all these microorganisms are
either well characterised oncogenic viruses or bacteria associated with cancer development.
A classic example is human papilloma virus (HPV), the major risk factor for cervical cancer [109].
HPV is a non-enveloped double stranded DNA virus that infects cutaneous and mucosal epithelia
and relies on the host DNA replication machinery to ensure the replication of its genome. The initial
infection occurs within the dividing cells of the skin basal layers or the ectocervix. When the infected
cells differentiate and stop proliferating, the expression of the viral gene product E7 activates cell
cycle progression, by binding to and promoting the degradation of the tumour suppressor protein RB.
However, the unrestrained proliferation imposed by E7 induces OIS in the infected cells. This event is
prevented by the HPV E6 protein, which promotes p53 degradation. Based on their effects on the cell
cycle progression, E6 and E7 are classified as viral oncogenes [109].
Epstein–Barr virus (EBV) and Kaposi sarcoma virus (KSV) are oncogenic viruses belonging to the
family of double stranded DNA gamma herpes viruses. Both establish a latent infection in B cells (EBV
and KSV) or in the blood and lymphatic endothelial cells (KSV), characterised by the expression of a
limited number of viral proteins [110,111]. Initially, latent infection is believed to promote a strong
proliferative burst of the infected cells to enhance the virus pool, which can further reside in the infected
cells in a non-productive form (characterised by the expression of a limited number of viral genes,
known as latent antigens), until the switch to a lytic type of infection, where new virions are produced.
The proliferative burst induced by EBV and KSV has to overcome the RS, and these viruses
have adopted different strategies to negatively regulate this process. The initial infection of primary
B cells with EBV is associated with telomere erosion and the activation of telomeric DNA damage.
However, a proportion of these cells will activate a telomerase-independent mechanism, known as the
alternative lengthening of telomeres (ALT), regulated by the latent protein EBNA-1, and followed by
the activation of human telomerase (hTERT) at a later stage in EBV-immortalised lymphoblastoid B
cells (LCLs) [112,113]. A recent paper has demonstrated that the KSV promotes the proliferation of
lymphatic endothelial cells beyond the replicative senescent limit, and this process is driven by the
expression of the viral protein vCyclin, a homologue of the cellular cyclins D and E [20].
The transforming capacity of these viruses is a collateral damage of the pro-proliferative feature
associated with anti-apoptotic and anti-senescence responses in combination with the failure of the
host safeguard mechanisms due to: (i) the integration of the viral HPV genome and the constitutive
expression of the viral E6 and E7; (ii) the acquisition of additional mutations that escalate the process
of immortalisation to transformation (EBV, KSV); (iii) the lack of immune control of EBV-transformed
LCL as consequence of immunosuppression.
Acute infection with Chlamydia trachomatis in E1A immortalised fibroblasts has been associated
with the increased expression of TERT, resulting in: (i) a slight increase in telomere length, which was
sustained even after clearance of the bacterial infection; and (ii) a reduced telomeric γH2AX
phosphorylation in late passage cells [114]. These effects could promote the survival of cells with
a higher potential to acquire genomic instability, providing one possible molecular mechanism to
support the epidemiological correlation between C. trachomatis infection and cervical cancer [115].
It would be interesting to assess whether the enhanced TERT expression is required to establish a
suitable niche for C. trachomatis replication.
3.4. Bacterial-Induced Senescence and Modulation of the Tissue Microenvironment
A relevant biological question concerning the evolution of bacterial genotoxins and the consequent
induction of senescence, is what role they exert in the context of infection and colonisation. Recent
evidence has demonstrated that a functional typhoid toxin prevents intestinal inflammation in amurine
model of Salmonella enterica [104], in spite of the induction of epithelial and stromal senescent cells
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during an acute infection (Martin and Frisan, unpublished data). This effect is associated with the
activation of a tissue repair-type of immune response, characterised by the presence of alternatively
activated-like macrophages and Th2 cytokines, such as IL-9, IL-10, and IL-13 (Martin and Frisan,
unpublished data). Infection with the genotoxigenic Salmonella favours the establishment of a persistent
infection in the liver, however, whether this effect is associated with the induction of senescence has
not yet been addressed [104]. These data suggest that during the course of a natural infection, the effect
of the genotoxin-induced senescence remodels the host response to promote a favourable niche for the
successful stealth invasion and establishment of chronic asymptomatic carriers as a pathogen reservoir.
Clostridium difficile is the causative agent of antibiotic-associateddiarrhoea andpseudomembranous
colitis. The key virulence factors in the pathogenesis of C. difficile are two protein toxins, the C. difficile
toxins A and B (TcdA and TcdB), which glucosylate and inactivate the small GTPases of the RHO family
(RHOA, RAC and CDC42), promoting cell rounding, loss of adhesion and apoptosis [116]. A novel
interesting aspect of TcdB is the induction of a senescence phenotype in enteric glial cells (EGC) that
survive the acute cytotoxicity [117]. The phenotype, which is AKT and JNK-dependent, may contribute
to the development of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) as a
consequence of C. difficile infection, via the prolonged secretion of pro-inflammatory mediators [117].
A senescence-dependent remodelling of the microenvironment been demonstrated also for
colibactin in the context of carcinogenesis. The exposure of cancer cells to colibactin producing
E. coli enhances tumour growth in a xenograft mouse model. This effect is dependent on the
colibactin-induced senescent phenotype, following the accumulation of the sumoylated form of
the tumour suppressor protein p53, and directly mediated by the microRNA miR20a-5p-induced
downregulation of deSumoylase Sentrin specific protease (SENP)-1. Tumour growth is fuelled by the
SASP, and specifically by the secretion of the hepatocyte growth factor (HGF). The activation of the HGF
pathway and the high expression of miR20a-5p has been further observed in an azoxymethane/dextran
sodium sulfate (AOM/DSS) mouse model of colorectal carcinoma (CRC) and in CRC human biopsies
positive for E. coli producing colibactin [18].
4. Concluding Remarks
The current knowledge on the crosstalk between cellular senescence and infection is still in its
infancy, but it highlights that senescence can exert a dual role in infection, either enhancing susceptibility
to infection by: (i) promoting immunosenescence; (ii) favouring microbial replication within the host
cells; (iii) the remodelling of the tissue microenvironment, or acting as part of the innate immune
defence thus restricting pathogen replication. The yin and yang effect may be dependent on multiple
variables, including the origin and differentiation stage of the infected cells, the microorganism,
the tissue microenvironment and type of infection (acute vs. persistent).
Many questions still need to be addressed, including a multi-markers characterisation of T cell
immunosenescence in chronic infections, the detection of senescence and its role in in vivo infections,
the detailed analysis of the SASP and whether different conditions/infections would promote different
types of secretory profiles. The technological development with the possibility to perform multiplex
analysis ex vivo and in situ (single cell sequencing, mass cytometry, multiplex transcriptomics) as well
as the use of senolytic compounds will allow researchers to address these issues.
Identifying the role of senescence in infections may provide the rational to design therapeutic
interventions based on senolytics to eliminate senescent cells as a mean to manage persistent infections
or overwhelming host immunoresponses as recently suggested for HIV and SARS-CoV-2 [118–120].
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